Markus Eickmann

13.0k total citations · 2 hit papers
74 papers, 4.1k citations indexed

About

Markus Eickmann is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Markus Eickmann has authored 74 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Infectious Diseases, 37 papers in Epidemiology and 11 papers in Molecular Biology. Recurrent topics in Markus Eickmann's work include Viral Infections and Outbreaks Research (22 papers), Viral Infections and Vectors (20 papers) and Virology and Viral Diseases (14 papers). Markus Eickmann is often cited by papers focused on Viral Infections and Outbreaks Research (22 papers), Viral Infections and Vectors (20 papers) and Virology and Viral Diseases (14 papers). Markus Eickmann collaborates with scholars based in Germany, Italy and Switzerland. Markus Eickmann's co-authors include Maren Eggers, Stephan Becker, Wolfgang Garten, Hans‐Dieter Klenk, Torsten Koburger‐Janssen, Konrad Stadler, Sergio Abrignani, Rino Rappuoli, Vega Masignani and Eva Böttcher‐Friebertshäuser and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Markus Eickmann

73 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells

2020 598 citations Miriam Ruth Heindl, Hannah Limburg et al. Life Science Alliance profile →
In Vitro Bactericidal and Virucidal Efficacy of Povidone-Iodine Gargle/Mouthwash Against Respiratory and Oral Tract Pathogens

2018 274 citations Maren Eggers, Markus Eickmann et al. Infectious Diseases and Therapy profile →

Peers

Countries citing papers authored by Markus Eickmann

Since Specialization

Citations

This map shows the geographic impact of Markus Eickmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Eickmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Eickmann more than expected).

Fields of papers citing papers by Markus Eickmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Eickmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Eickmann. The network helps show where Markus Eickmann may publish in the future.

Co-authorship network of co-authors of Markus Eickmann

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Eickmann. A scholar is included among the top collaborators of Markus Eickmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Eickmann. Markus Eickmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Rescue and characterization of the first West African Marburg virus 2021 from Guinea 2023 ·Heliyon ·(unknown), Gesche K. Gerresheim, Clemens Lier, Jana Schneider, Martin Schauflinger, Marcel Benz, (unknown), Cornelius Rohde, Markus Eickmann, Nadine Biedenkopf	3
2	Protective CD8+ T Cell Response Induced by Modified Vaccinia Virus Ankara Delivering Ebola Virus Nucleoprotein 2022 ·Vaccines ·Alexandra Kupke, Asisa Volz, Erik Dietzel, (unknown), Jörg Schmidt, Hosam Shams-Eldin, Sylvia Jany, Lucie Sauerhering, Verena Krähling, (unknown), Christiane Herden, Markus Eickmann, Stephan Becker, Gerd Sutter	10
3	Multiple Orientia clusters and Th1-skewed chemokine profile: a cross-sectional study in patients with scrub typhus from Nepal 2022 ·International Journal of Infectious Diseases ·(unknown), (unknown), Binod Rayamajhee, Anurag Adhikari, (unknown), (unknown), (unknown), Markus Eickmann, Christian Bauer, Krishna Das Manandhar, Christian Keller	9
4	TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells breakdown → 2020 ·Life Science Alliance ·(unknown), Miriam Ruth Heindl, Hannah Limburg, (unknown), Oliver Pilgram, Hong M. Moulton, David A. Stein, Kornelia Hardes, Markus Eickmann, Olga Dolnik, Cornelius Rohde, Hans-Dieter Klenk, Wolfgang Garten, Torsten Steinmetzer, Eva Böttcher‐Friebertshäuser	598
5	Acetylcholine Receptor Antibody Titers and Clinical Course after Influenza Vaccination in Patients with Myasthenia Gravis: A Double-Blind Randomized Controlled Trial (ProPATIent-Trial) 2018 ·EBioMedicine ·Björn Tackenberg, M Schneider, Franz Blaes, (unknown), Carmen Schade‐Brittinger, (unknown), Marcus Deschauer, Markus Eickmann, Hans‐Dieter Klenk, Hans‐Helge Müller, Norbert Sommer	17
6	Virucidal Activity of World Health Organization–Recommended Formulations Against Enveloped Viruses, Including Zika, Ebola, and Emerging Coronaviruses 2017 ·The Journal of Infectious Diseases ·(unknown), Stephanie Pfaender, Nathalie J. Vielle, Ronald Dijkman, Martina Friesland, Britta Becker, Jaewon Yang, Michael Engelmann, Daniel Tödt, Marc P. Windisch, Florian H. H. Brill, Joerg Steinmann, Jochen Steinmann, Stephan Becker, Marco P. Alves, Thomas Pietschmann, Markus Eickmann, Volker Thiel, Eike Steinmann	158
7	Marburg Biosafety and Biosecurity Scale (MBBS): A Framework for Risk Assessment and Risk Communication 2015 ·Health Security ·Petra Dickmann, Franklin Apfel, Nadine Biedenkopf, Markus Eickmann, Stephan Becker	3
8	Povidone-iodine hand wash and hand rub products demonstrated excellent in vitro virucidal efficacy against Ebola virus and modified vaccinia virus Ankara, the new European test virus for enveloped viruses 2015 ·BMC Infectious Diseases ·Maren Eggers, Markus Eickmann, (unknown), (unknown), K. Reimer	63
9	Rapid and Effective Virucidal Activity of Povidone-Iodine Products Against Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and Modified Vaccinia Virus Ankara (MVA) 2015 ·Infectious Diseases and Therapy ·Maren Eggers, Markus Eickmann, (unknown)	174
10	Field Evaluation of Capillary Blood Samples as a Collection Specimen for the Rapid Diagnosis of Ebola Virus Infection During an Outbreak Emergency 2015 ·Clinical Infectious Diseases ·Thomas Strecker, Bernadett Pályi, Heinz Ellerbrok, Sylvie Jonckheere, Hilde De Clerck, Joseph Akoi Boré, Martin Gabriel, Kilian Stoecker, Markus Eickmann, Michel Van Herp, Pierre Formenty, Antonino Di, (unknown)	25
11	Biosafety Level-4 Laboratories in Europe: Opportunities for Public Health, Diagnostics, and Research 2013 ·PLoS Pathogens ·Carla Nisii, Concetta Castilletti, Hervé Raoul, Roger Hewson, David W. Brown, Robin Gopal, Markus Eickmann, Stephan Günther, Alì Mirazimi, Tuija Koivula, Heinz Feldmann, Antonino Di, Maria Rosaria Capobianchi, Giuseppe Ippolito	15
12	Human Cell Tropism and Innate Immune System Interactions of Human Respiratory Coronavirus EMC Compared to Those of Severe Acute Respiratory Syndrome Coronavirus 2013 ·Journal of Virology ·Florian Zielecki, Michaela Weber, Markus Eickmann, (unknown), (unknown), Mikhail Matrosovich, Stephan Becker, Friedemann Weber	115
13	SARS — beginning to understand a new virus 2003 ·Nature Reviews Microbiology ·Konrad Stadler, Vega Masignani, Markus Eickmann, Stephan Becker, Sergio Abrignani, Hans‐Dieter Klenk, Rino Rappuoli	396
14	Crystal Structure of the Borna Disease Virus Nucleoprotein 2003 ·Structure ·M.G. Rudolph, (unknown), Achim Dickmanns, Markus Eickmann, Wolfgang Garten, Ralf Ficner	83
15	Identification of Lassa virus glycoprotein signal peptide as a trans-acting maturation factor 2003 ·EMBO Reports ·R. Eichler, Oliver Lenz, Thomas Strecker, Markus Eickmann, Hans‐Dieter Klenk, Wolfgang Garten	57
16	Crystallization and preliminary X-ray analysis of the matrix protein of Borna disease virus 2002 ·Acta Crystallographica Section D Biological Crystallography ·(unknown), (unknown), Markus Eickmann, (unknown), Milton T. Stubbs, Wolfgang Garten	4
17	Human Cytomegalovirus-Mediated Induction of MIF in Fibroblasts 2002 ·Virology ·Michael Bacher, Markus Eickmann, J. Schrader, Diethard Gemsa, (unknown)	20
18	A mono phenylalanine-based motif (F790) and a leucine-dependent motif (LI760) mediate internalization of furin 1999 ·European Journal of Cell Biology ·Annemarie Stroh, Wolfram Schäfer, (unknown), Markus Eickmann, (unknown), (unknown), Hans‐Dieter Klenk, Wolfgang Garten	15
19	Effect of cysteine substitutions on dimerization and interfragment linkage of human cytomegalovirus glycoprotein B (gp UL55) 1998 ·Archives of Virology ·Markus Eickmann, Roland Lange, Mats Ohlin, (unknown), K. Radsak	4
20	Retrieval of human cytomegalovirus glycoprotein B from the infected cell surface for virus envelopment 1996 ·Archives of Virology ·K. Radsak, Markus Eickmann, (unknown), Elke Bogner, H. Kern, Anna Maria Eis‐Hübinger, (unknown)	71

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact